These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Dysferlin and muscular dystrophy. Bushby KM Acta Neurol Belg; 2000 Sep; 100(3):142-5. PubMed ID: 11098285 [TBL] [Abstract][Full Text] [Related]
23. Localization of the region homologous to the Duchenne muscular dystrophy locus on the mouse X chromosome. Heilig R; Lemaire C; Mandel JL; Dandolo L; Amar L; Avner P Nature; 1987 Jul 9-15; 328(6126):168-70. PubMed ID: 3600794 [TBL] [Abstract][Full Text] [Related]
25. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538 [TBL] [Abstract][Full Text] [Related]
26. Myoblast transfer in muscular dystrophy: panacea or pie in the sky? Dubowitz V Neuromuscul Disord; 1992; 2(5-6):305-10. PubMed ID: 1300179 [No Abstract] [Full Text] [Related]
27. Protein degradation in cultured skeletal muscle from Duchenne muscular dystrophy patients. Neville HE; Harrold S Muscle Nerve; 1985; 8(3):253-7. PubMed ID: 4058470 [TBL] [Abstract][Full Text] [Related]
28. [Characteristics of lipid metabolism of the skeletal muscles in progressive muscular dystrophy]. Badalian LO; Grinio LP; Temin PA; Islamova IB; Il'in IL Pediatriia; 1983 Jan; (1):66-8. PubMed ID: 6340057 [No Abstract] [Full Text] [Related]
29. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Matsumura K; Campbell KP Muscle Nerve; 1994 Jan; 17(1):2-15. PubMed ID: 8264699 [TBL] [Abstract][Full Text] [Related]
30. Biochemical approaches to the study of muscle disease. Peter JB Birth Defects Orig Artic Ser; 1971 Feb; 7(2):38-42. PubMed ID: 5173127 [TBL] [Abstract][Full Text] [Related]
31. Membrane defects in Duchenne dystrophy: protease affecting sarcoplasmic reticulum. Nagy B; Samaha FJ Ann Neurol; 1986 Jul; 20(1):50-6. PubMed ID: 3527039 [TBL] [Abstract][Full Text] [Related]
32. [Research on the molecular mechanisms of the pathogenesis of myodystrophies and the systematic approach to the study of human proteins (a review)]. Shishkin SS; Kovalev LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(3):119-23. PubMed ID: 3289286 [No Abstract] [Full Text] [Related]
33. [The amino acid composition of the myosin and actin of the muscles of animals with hereditary myopathies]. Badalian LO; Bondarenko ES; Gusev EI; Lukoianov IuE; Revich GG; Temin PA; Sharets IuD Biull Eksp Biol Med; 1970 Feb; 69(2):112-4. PubMed ID: 5424226 [No Abstract] [Full Text] [Related]
34. Muscle development in mdx mutant mice. Dangain J; Vrbova G Muscle Nerve; 1984; 7(9):700-4. PubMed ID: 6543918 [TBL] [Abstract][Full Text] [Related]
35. Nerve, muscle and muscular dystrophy. Bradley WG Dev Med Child Neurol; 1971 Aug; 13(4):528-31. PubMed ID: 5558753 [No Abstract] [Full Text] [Related]
36. A variation in growth capability of myofibers shifted to incompetence as the pathogenesis of mouse muscular dystrophy. Totsuka T; Uramoto I Nihon Seirigaku Zasshi; 1986; 48(10):703-6. PubMed ID: 3820122 [No Abstract] [Full Text] [Related]
37. [Muscle-calcium-activated protease and its inhibitors]. Ishiura S; Imahori K Nihon Rinsho; 1977 Nov; 35(11):3910-4. PubMed ID: 599672 [No Abstract] [Full Text] [Related]